About us
Lorem ipsum sint occaecat cupidatat nondolor sit amet elitase.
Ut enim ad minim veniam, quis nostrud
Lynx Biosciences, Inc. (LynxBio®) is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients.
As a (re)mission-driven company, we leverage this clinically-proven platform to address unmet medical needs in oncology, with an initial focus on hematological malignancies. To date, we have entered into collaborations with 10+ NCI-designated cancer centers as well as Top 20 pharmaceutical companies to advance promising drug candidates and identify predictive biomarkers in clinical studies.
Board of Directors
Name
Title
Name
Title
Name
Title
Name
Title
"Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum."
Board of Advisors
Name
Title
Name
Title
Name
Title
Name
Title